$ITOX
IIOT-OXYS, Inc. Stock $itox

$itox Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000168316823002351 Filed on April 13, 2023

Income Statement

Concept	2023 Q2	2022 Q4	2022
Revenue	$35.29K	$49.40K	$88.90K
YoY Change	113.87%	723.33%	688.16%
Cost Of Revenue	$8.495K	$4.850K	$10.50K
YoY Change	1565.69%	529.87%	414.66%
Gross Profit	$26.79K	$44.55K	$78.41K
YoY Change	67.57%	751.82%	748.54%
Gross Profit Margin	75.93%	90.18%	88.19%
Selling, General & Admin	$117.7K	$140.1K	$683.6K
YoY Change	-45.9%	37.89%	-18.54%
% of Gross Profit	439.43%	314.52%	871.84%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$12.34K	$12.48K	$49.50K
YoY Change	0.0%	0.08%	-0.54%
% of Gross Profit	46.06%	28.01%	63.13%
Operating Expenses	$130.1K	$152.6K	$733.1K
YoY Change	-43.43%	33.74%	-17.55%
Operating Profit	-$103.3K	-$108.1K	-$654.7K
YoY Change	-51.73%	-0.75%	-25.6%
Interest Expense	$14.00K	-$172.6K	$377.1K
YoY Change	-14.23%	3.0%	-214.97%
% of Operating Profit
Other Income/Expense, Net	-$163.5K		-$369.6K
YoY Change	-743.62%		-891.35%
Pretax Income	-$266.8K	-$280.6K	-$1.024M
YoY Change	41.46%	17.07%	-1.63%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$266.8K	-$301.7K	-$1.024M
YoY Change	41.46%	25.84%	-1.63%
Net Earnings / Revenue	-755.93%	-610.65%	-1152.06%
Basic Earnings Per Share	$0.00		$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	401.9M shares	321.6M shares	273.2M shares
Diluted Shares Outstanding	405.3M shares		273.2M shares

Balance Sheet

Concept	2023 Q2	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.900K	$33.34K	$33.34K
YoY Change	-89.25%	-28.79%	-28.79%
Cash & Equivalents	$7.896K	$33.34K	$33.34K
Short-Term Investments
Other Short-Term Assets	$12.76K	$7.770K	$7.770K
YoY Change	64.22%	0.0%	0.0%
Inventory
Prepaid Expenses		$7.773K
Receivables	$25.35K	$28.94K	$28.94K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$46.01K	$70.05K	$70.05K
YoY Change	-57.81%	6.34%	6.35%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$421.2K	$443.9K	$443.9K
YoY Change	-9.8%	48.91%	48.9%
TOTAL ASSETS
Total Short-Term Assets	$46.01K	$70.05K	$70.05K
Total Long-Term Assets	$421.2K	$443.9K	$443.9K
Total Assets	$467.2K	$513.9K	$513.9K
YoY Change	-18.89%	41.2%	41.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$215.0K	$133.4K	$133.4K
YoY Change	37.1%	-17.23%	-17.22%
Accrued Expenses	$469.0K	$395.7K	$659.2K
YoY Change	56.12%	60.11%	26.51%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$310.0K	$363.2K	$363.2K
YoY Change	-24.84%	55.75%	55.75%
Total Short-Term Liabilities	$1.977M	$1.677M	$1.677M
YoY Change	17.67%	42.75%	42.75%
LONG-TERM LIABILITIES
Long-Term Debt	$124.3K	$104.3K	$104.3K
YoY Change	126.0%	-60.96%	-60.96%
Other Long-Term Liabilities	$1.000K	$1.000K	$1.000K
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Liabilities	$125.3K	$105.3K	$105.3K
YoY Change	123.75%	-60.73%	-60.73%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.977M	$1.677M	$1.677M
Total Long-Term Liabilities	$125.3K	$105.3K	$105.3K
Total Liabilities	$2.102M	$1.782M	$1.782M
YoY Change	21.09%	23.52%	23.52%
SHAREHOLDERS EQUITY
Retained Earnings	-$9.768M	-$9.307M
YoY Change	9.07%	8.93%
Common Stock	$406.8K	$352.2K
YoY Change	44.88%	59.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.180M	-$1.813M	-$1.268M
YoY Change
Total Liabilities & Shareholders Equity	$467.2K	$513.9K	$513.9K
YoY Change	-18.89%	41.2%	41.2%

Cashflow Statement

Concept	2023 Q2	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$266.8K	-$301.7K	-$1.024M
YoY Change	41.46%	25.84%	-1.63%
Depreciation, Depletion And Amortization	$12.34K	$12.48K	$49.50K
YoY Change	0.0%	0.08%	-0.54%
Cash From Operating Activities	-$17.26K	-$185.5K	-$657.0K
YoY Change	-90.9%	74.64%	4.6%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	-$200.0K
YoY Change	-100.0%
Cash From Investing Activities	$0.00	$0.00	-$200.0K
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	184.5K	$843.5K
YoY Change	-100.0%	269.0%	47.51%
NET CHANGE
Cash From Operating Activities	-17.26K	-185.5K	-$657.0K
Cash From Investing Activities	0.000	0.000	-$200.0K
Cash From Financing Activities	0.000	184.5K	$843.5K
Net Change In Cash	-17.26K	-950.0	-$13.49K
YoY Change	-85.1%	-98.31%	-76.03%
FREE CASH FLOW
Cash From Operating Activities	-$17.26K	-$185.5K	-$657.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001290658
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021	ITOX	Common Stock Issued For Financing Commitment CommonStockIssuedForFinancingCommitment		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-50773
CY2022	dei	Entity Registrant Name EntityRegistrantName	IIOT-OXYS, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	81-3485426
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	705 Cambridge Street
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Cambridge
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02141
CY2022	dei	City Area Code CityAreaCode	(401)
CY2022	dei	Local Phone Number LocalPhoneNumber	307-3092
CY2022	dei	Security12g Title Security12gTitle	Common Stock, Par Value $0.001
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	1756676	usd
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	401865786	shares
CY2022	dei	Auditor Name AuditorName	Haynie & Company
CY2022	dei	Auditor Location AuditorLocation	Salt Lake City, Utah
CY2022	dei	Auditor Firm AuditorFirmId	457
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33336	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46821	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	28941	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	11280	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7773	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7773	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	70050	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	65874	usd
CY2022Q4	ITOX	Originall Issuance Discount On Note Receivable OriginallIssuanceDiscountOnNoteReceivable	4716	usd
CY2021Q4	ITOX	Originall Issuance Discount On Note Receivable OriginallIssuanceDiscountOnNoteReceivable	0	usd
CY2022Q4	ITOX	Note Receivable Net NoteReceivableNet	195284	usd
CY2021Q4	ITOX	Note Receivable Net NoteReceivableNet	0	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	248585	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	298085	usd
CY2022Q4	us-gaap	Assets Assets	513919	usd
CY2021Q4	us-gaap	Assets Assets	363959	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	133408	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	161171	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	395714	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	247155	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	31425	usd
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	46425	usd
CY2022Q4	ITOX	Unearned Interests UnearnedInterests	5151	usd
CY2021Q4	ITOX	Unearned Interests UnearnedInterests	0	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	0	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	57148	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	363167	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	233167	usd
CY2022Q4	ITOX	Shares Payable To Related Parties SharesPayableToRelatedParties	14624	usd
CY2021Q4	ITOX	Shares Payable To Related Parties SharesPayableToRelatedParties	0	usd
CY2022Q4	ITOX	Salaries Payable To Related Parties SalariesPayableToRelatedParties	263516	usd
CY2021Q4	ITOX	Salaries Payable To Related Parties SalariesPayableToRelatedParties	273926	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	469873	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	202616	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1676878	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1164460	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	104300	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	267152	usd
CY2022Q4	ITOX	Due To Stockholders DueToStockholders	1000	usd
CY2021Q4	ITOX	Due To Stockholders DueToStockholders	1000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1782178	usd
CY2021Q4	us-gaap	Liabilities Liabilities	1432612	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	544800	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	247200	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	26	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	26	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	352174583	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	352174583	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	220254395	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	220254395	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	352175	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	220255	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	7141877	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	7008098	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9307137	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8544232	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1813059	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1315853	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	513919	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	363959	usd
CY2022	us-gaap	Revenues Revenues	88904	usd
CY2021	us-gaap	Revenues Revenues	11280	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	10499	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	2040	usd
CY2022	us-gaap	Gross Profit GrossProfit	78405	usd
CY2021	us-gaap	Gross Profit GrossProfit	9240	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	683571	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	839370	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	49500	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	49771	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	733071	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	889141	usd
CY2022	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	190462	usd
CY2021	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	102966	usd
CY2022	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-200519	usd
CY2021	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	120000	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	17634	usd
CY2021	us-gaap	Interest Income Other InterestIncomeOther	0	usd
CY2022	us-gaap	Interest Expense InterestExpense	377138	usd
CY2021	us-gaap	Interest Expense InterestExpense	430999	usd
CY2022	us-gaap	Other Income OtherIncome	0	usd
CY2021	us-gaap	Other Income OtherIncome	46700	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-369561	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-161333	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1024227	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1041234	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1024227	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1041234	usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	52654	usd
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	22320	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1076881	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1063554	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	273238664	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	273238664	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	195264873	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	195264873	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-2541280	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	323520	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	532500	usd
CY2021	ITOX	Common Stock Issued For Extension Of Notes Payable CommonStockIssuedForExtensionOfNotesPayable	11125	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	360000	usd
CY2021	ITOX	Commission Paids For Raising Capital CommissionPaidsForRaisingCapital	-11650	usd
CY2021	ITOX	Common Stock Issued For Accrued Compensation CommonStockIssuedForAccruedCompensation	1064786	usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	8700	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1063554	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1315853	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	90000	usd
CY2022	ITOX	Common Stock Issued For Financing Commitment CommonStockIssuedForFinancingCommitment	557065	usd
CY2022	ITOX	Sales Commissions Paid For Capital Raise SalesCommissionsPaidForCapitalRaise	-11141	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	900	usd
CY2022	ITOX	Beneficial Conversion Feature Associated With Discounts BeneficialConversionFeatureAssociatedWithDiscounts	-57149	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1076881	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1813059	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1076881	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1063554	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	900	usd
CY2021	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	usd
CY2022	ITOX	Discount On Notes Receivable DiscountOnNotesReceivable	4716	usd
CY2021	ITOX	Discount On Notes Receivable DiscountOnNotesReceivable	0	usd
CY2022	ITOX	Forgiveness Of Ppp Loan ForgivenessOfPppLoan	-0	usd
CY2021	ITOX	Forgiveness Of Ppp Loan ForgivenessOfPppLoan	36700	usd
CY2022	ITOX	Discount On Notes Payable DiscountOnNotesPayable	-0	usd
CY2021	ITOX	Discount On Notes Payable DiscountOnNotesPayable	129380	usd
CY2022	ITOX	Amortization Of Beneficial Conversion Feature AmortizationOfBeneficialConversionFeature	0	usd
CY2021	ITOX	Amortization Of Beneficial Conversion Feature AmortizationOfBeneficialConversionFeature	360000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	49500	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	49771	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	17661	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11280	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-0	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	5346	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-27763	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-8743	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	148558	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	110789	usd
CY2022	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	267257	usd
CY2021	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-102966	usd
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	5151	usd
CY2021	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	0	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-15000	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	usd
CY2022	ITOX	Increase Decrease In Shares Payable To Related Parties IncreaseDecreaseInSharesPayableToRelatedParties	14624	usd
CY2021	ITOX	Increase Decrease In Shares Payable To Related Parties IncreaseDecreaseInSharesPayableToRelatedParties	342650	usd
CY2022	ITOX	Increase Decrease In Salaries Payable To Related Parties IncreaseDecreaseInSalariesPayableToRelatedParties	-10410	usd
CY2021	ITOX	Increase Decrease In Salaries Payable To Related Parties IncreaseDecreaseInSalariesPayableToRelatedParties	-133345	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-657009	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-628103	usd
CY2022	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	200000	usd
CY2021	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	-0	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-200000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	545924	usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	470850	usd
CY2022	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	297600	usd
CY2021	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	101000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	843524	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	571850	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-13485	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-56253	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	46821	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	103074	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33336	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	46821	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	ITOX	Discount On Notes Payables DiscountOnNotesPayables	32852	usd
CY2021	ITOX	Discount On Notes Payables DiscountOnNotesPayables	26833	usd
CY2022	ITOX	Conversion Of Convertible Notes Payable And Derivative Liabilities ConversionOfConvertibleNotesPayableAndDerivativeLiabilities	90000	usd
CY2021	ITOX	Conversion Of Convertible Notes Payable And Derivative Liabilities ConversionOfConvertibleNotesPayableAndDerivativeLiabilities	288029	usd
CY2022	ITOX	Warrant Antidilution Issuance WarrantAntidilutionIssuance	0	usd
CY2021	ITOX	Warrant Antidilution Issuance WarrantAntidilutionIssuance	203597	usd
CY2022	ITOX	Discount On Series B Preferred Stock DiscountOnSeriesBPreferredStock	297600	usd
CY2021	ITOX	Discount On Series B Preferred Stock DiscountOnSeriesBPreferredStock	247200	usd
CY2022Q4	ITOX	Working Capital WorkingCapital	1076881	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-657009	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9307137	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33336	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46821	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zDEhBAYXxHve" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_866_zzOhXW84GUYj">Concentration of Credit Risk</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially expose the Company to concentrations of risk consist primarily of cash and cash equivalents which are generally not collateralized. The Company’s policy is to place its cash and cash equivalents with high quality financial institutions, in order to limit the amount of credit exposure. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (FDIC), up to $250,000. At December 31, 2022 and December 31, 2021, the Company had <span id="xdx_90B_eus-gaap--CashUninsuredAmount_iI_pp0p0_do_c20221231_zUjLB1rLCV7a" title="Cash in excess of FDIC insurance"><span id="xdx_903_eus-gaap--CashUninsuredAmount_iI_pp0p0_do_c20211231_zCMmtvmPxDAb" title="Cash in excess of FDIC insurance">no</span></span> amounts in excess of the FDIC insurance limit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	0	usd
CY2021Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	0	usd
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	195264873	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	248585	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	298085	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	495000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	495000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	246415	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	196915	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	248585	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	298085	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	49500	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	49771	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	0	shares
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	49500	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	49500	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	49500	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	49500	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	50585	usd
CY2022Q4	us-gaap	Intangible Assets Current IntangibleAssetsCurrent	248585	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	543167	usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	633167	usd
CY2022Q4	ITOX	Deferred Financing Costs DeferredFinancingCosts	-75700	usd
CY2021Q4	ITOX	Deferred Financing Costs DeferredFinancingCosts	-75700	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	-0	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	57158	usd
CY2022Q4	ITOX	Convertible Notes Payable Net ConvertibleNotesPayableNet	467467	usd
CY2021Q4	ITOX	Convertible Notes Payable Net ConvertibleNotesPayableNet	500319	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	363167	usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	233167	usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	104300	usd
CY2021Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	267152	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	364868	usd
CY2021Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	426036	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1076881	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1063554	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	273238664	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	273238664	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	195264873	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	369865312	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	331684858	shares
CY2022	us-gaap	Proceeds From Loans ProceedsFromLoans	36700	usd
CY2021Q3	ITOX	Ppp Loan Current PppLoanCurrent	36700	usd
CY2021	us-gaap	Other Noncash Income OtherNoncashIncome	10000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	352174583	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	220254395	shares
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	469873	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	202616	usd
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3043397	shares
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.01229
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P3Y4M24D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	175000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0.20
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2868397	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.01229
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P2Y4M24D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	0	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	0	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	0	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2868397	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.00084
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P1Y4M24D
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-226145	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-223346	usd
CY2022	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-52229	usd
CY2021	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-51582	usd
CY2022	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	278374	usd
CY2021	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	274929	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0485	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0485	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.0024	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.0250	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2561	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2835	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2405788	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2130588	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2405788	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2130588	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2405788	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2130588	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	9307000	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	8242000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
itox-20221231_cal.xml	Edgar Link	unprocessable
itox-20221231_lab.xml	Edgar Link	unprocessable
0001683168-23-002351-index-headers.html	Edgar Link	pending
0001683168-23-002351-index.html	Edgar Link	pending
0001683168-23-002351.txt	Edgar Link	pending
0001683168-23-002351-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
iiot_ex1035.htm	Edgar Link	pending
iiot_ex3101.htm	Edgar Link	pending
iiot_ex3102.htm	Edgar Link	pending
iiot_ex3201.htm	Edgar Link	pending
iiot_ex3202.htm	Edgar Link	pending
iiot_i10k-123122.htm	Edgar Link	pending
itox-20221231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
itox-20221231_def.xml	Edgar Link	unprocessable
itox-20221231_pre.xml	Edgar Link	unprocessable
iiot_i10k-123122_htm.xml	Edgar Link	completed
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ITOX
IIOT-OXYS, Inc. Stock $itox

2023 Q2 Form 10-K Financial Statement

#000168316823002351 Filed on April 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ITOX IIOT-OXYS, Inc. Stock $itox

2023 Q2 Form 10-K Financial Statement

#000168316823002351 Filed on April 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ITOX
IIOT-OXYS, Inc. Stock $itox